In the BioHarmony Drug Report Database

"Preview" Icon

Testosterone undecanoate

Aveed, Jatenzo (testosterone undecanoate) is a small molecule pharmaceutical. Testosterone undecanoate was first approved as Aveed on 2014-03-05. It is used to treat breast neoplasms, delayed puberty, and hypogonadism in the USA. Aveed’s patents are valid until 2030-12-20 (FDA).

 

Trade Name

 

Aveed, Jatenzo
 

Common Name

 

testosterone undecanoate
 

ChEMBL ID

 

CHEMBL2107067
 

Indication

 

breast neoplasms, delayed puberty, hypogonadism
 

Drug Class

 

Steroids (androgens, anabolics)

Image (chem structure or protein)

Testosterone undecanoate structure rendering